Key Insights

Highlights

Treatment Research

5 treatments under study, led by Ltld

Research Leaders

7 sponsors active, led by UMC Utrecht

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 1 (1)

Trial Status

Recruiting2
Unknown1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07723209Not ApplicableRecruiting

Radiation After No Axillary Nodal Sampling

NCT04985032Recruiting

Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)

NCT03749850Phase 1Unknown

Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer

Showing all 3 trials

Research Network

Common Treatments

  • Ltld1
  • Mrhifu Induced Hyperthermia1
  • Cyclophosphamide1
  • Stereotactic Body Radiation Therapy1
  • Partial Breast Irradiation Pbi1

Active Sponsors

  • UMC Utrecht1
  • Vrienden UMC Utrecht1
  • Center for Translational Molecular Medicine1
  • Dutch Cancer Society1
  • NYU Langone Health1

Top Investigators

Related Conditions

  • Breast Cancer1
  • Metastatic Breast Cancer1
  • Adenocarcinoma Breast1
  • Ductal Carcinoma In Situ1
  • Breast Neoplasms1

Activity Timeline